ResMed Inc (RMD)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE
Market Cap: $33.69B
Last updated: Nov 17, 2026 at 4:33 PM ET
ResMed Inc (RMD) Stock Chart
ResMed (RMD) has a latest price of $237.95 on Nov 17, 2026, 13.4% below its 52-week high of $274.65. Its price fell 2.1% over the past 12 months. The month-end price rose 284.7% over the 10 years through Oct 2026, a compound annual rate of 14.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $290.53 in Aug 2021 and its lowest $59.77 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RMD with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RMD.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 3.7%, and over 6 months it rose 14.9%. The month-end price rose 62.8% over the 3 years through Oct 2026, a compound annual rate of 17.6%.
| Period | Change |
|---|---|
| 1 month | -0.5% |
| 3 months | +3.7% |
| 6 months | +14.9% |
| 12 months | -2.1% |
| 12 months, with dividends | -1.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +62.8% | +17.6% |
| 5 years | -12.5% | -2.6% |
| 10 years | +284.7% | +14.4% |
Price by Year
Its best calendar year was 2020, when the price rose 37.2%, and its weakest was 2022, when it fell 20.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $229.94 | -4.5% |
| 2025 | $240.87 | +5.3% |
| 2024 | $228.69 | +32.9% |
| 2023 | $172.02 | -17.3% |
| 2022 | $208.13 | -20.1% |
| 2021 | $260.48 | +22.5% |
| 2020 | $212.56 | +37.2% |
| 2019 | $154.97 | +36.1% |
| 2018 | $113.87 | +34.5% |
| 2017 | $84.69 | +36.5% |
Trading Range
The price is 2.5% above its 50-day average of $232.10 and 6.8% above its 200-day average of $222.83.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $237.95 | |
| 52-week high | $274.65 | -13.4% |
| 52-week low | $179.26 | +32.7% |
| 50-day average | $232.10 | +2.5% |
| 200-day average | $222.83 | +6.8% |
Price Risk
Over 3 years, its largest fall from a peak was 37.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.49 |
| Largest fall, 1 year | -33.6% |
| Largest fall, 3 years | -37.5% |
Valuation
ResMed traded at 23.4x earnings at the end of 2025, against a 5-year median of 27.8x and a 10-year median of 30.0x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RMD
What is RMD's 1-year price change?
ResMed's price fell 2.1% over the past 12 months. With dividends included, the 12-month total return was -1.1%.
What is RMD's 5-year price change?
ResMed's month-end price fell 12.5% over the 5 years through Oct 2026, a compound annual decline of 2.6%. These figures leave out dividends.
What is RMD's 52-week high and low?
ResMed's 52-week high is $274.65 and its 52-week low is $179.26. Its latest price of $237.95 on Nov 17, 2026 is 13.4% below the high.
What is RMD's beta?
ResMed's 1-year beta against the S&P 500 is 0.49, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 33.6%.
Is the RMD chart free?
Yes. Advanced Charting for RMD is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RMD pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors